- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590.
- Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore). 2006;85(1):37–42. doi:10.1097/01.md.0000198474.99876.f0.
- Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med. 2007;356(18):1862–1869. doi:10.1056/NEJMcp067190.
- Straka C, Ying J, Kong FM, Willey CD, Kaminski J, Kim DW. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus. 2016;5(1):229. doi:10.1186/s40064-016-1900-7.
- Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev. 2002;14(5), 338–351. https://doi.org/10.1053/clon.2002.0095.
- Fangio P, Alves M. Unexpected venous thrombosis in the superior vena cava. Am J Med. 2015;128(11):e17–e18. doi:10.1016/j.amjmed.2015.06.039.
- Healthcare Cost and Utilization Project. HCUP National Inpatient Sample (NIS). 2012.
- Wiredu C, Haynes N, Guerra C, Ky B. Racial and ethnic disparities in cancer-associated thrombosis. Thromb Haemost. 2021;122(5):662–665. doi:10.1055/a-1674-0259.
- Lutsey PL, Cushman M, Steffen LM, et al. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost. 2006;4(12):2629–2635. doi:10.1111/j.1538-7836.2006.02237.x.
- Friedman T, Quencer K, Kishore S, Winokur R, Madoff D. Malignant venous obstruction: Superior vena cava syndrome and beyond. Semin Intervent Radiol. 2017;34(4):398–408. doi:10.1055/s-0037-1608863.
- Phillips AR, Reitz KM, Myers S, et al. Association between Black race, clinical severity, and management of acute pulmonary embolism: a retrospective cohort study. J Am Heart Assoc. 2021;10(17):e021818. doi:10.1161/jaha.121.021818.
- Rodriguez M, Dai W, Lund H, et al. The correlation between racial/ethnic groups, thrombosis, and mortality in hospitalized patients with COVID-19. Blood. 2021;138(Suppl 1):3224–3224. doi:10.1182/blood-2021-153716.
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.